Appeal to the FDA: no more silence on puberty-blocking drugs

A petition asks the US drug agency -which has never authorised the off-label use of these substances for girls and boys with dysphoria- to counter the misinformation that propagates these treatments as effective and safe and to demand studies to prove it.Between 207 and 2021, the number of minors treated has more than doubled and the FDA can no longer pretend it is blind.
Please be aware that the translation of contents, although automatic, has a cost to Feminist Post but is provided to you without any charge. Please consider making a contribution via the "Support us" page if you intend to use our translation service intensively.
The contents of this site are translated using automatic translation systems without the intervention of professional translators.
Translations are provided for the sole purpose of facilitating reading by international visitors.
Share this article

On its website Gender Clinic News Bernard Lane gives news of a important petition addressed to the FDA (Food and Drug Administration, a drug regulatory body in the United States) to undertake aurgent action on the unapproved (off-label) use of hormone suppressant drugs to stop puberty in girls and boys who identify as transgender. Although this use has never been approved by the FDA, it is not possible for the institution to ignore the possible harm to minors who are subjected to these treatments.

Let us remember that while all over Northern Europe there is a slowdown, in Italy puberty blockers are regularly prescribed -the number of minors in treatment is not known- and that the Italian Society of Paediatrics claims that the use of these drugs does not cause permanent problems to children. Also for the president of the Italian Society of Endocrinology Annamaria Colao the drug that blocks puberty 'if used correctly has no side effects or irreversible effects'.

Following is the translation of thearticle by Bernard Lane.

Despite thewidespread - and rapidly growing - use of these drugs in this population [of children with gender dysphoria], and despite the serious risks known and potential from these drugs, this use has never been evaluated from the point of view of safety and effectiveness by experts'.  

The signatories of the petition include child and adolescent psychiatrist Miriam Grossmannpaediatric endocrinologist Quentin van Meter and the groups Genspect, Detrans Help, FAIR in Medicine and Gender Dysphoria Alliance.

"Puberty blockers, or gonadotropin-releasing hormone (GnRH) agonists, are a class of drugs FDA-approved for the treatment of certain cancers, endometriosis and, in paediatric populations, premature puberty. Branded puberty blockers include Lupron Depot-PED, Supprelin LA, Fensolvi, Synarel and Triptodur. These drugs suppress the release of sex-specific hormones: testosterone in males and oestrogen in females. When administered to children in the early stages of puberty, they delay sex-specific changes normal in adolescent development, such as deepening of the voice in males and breast development in females'.

The petitioners urge the FDA to

- mandate the National Academies of Sciences, Engineering and Medicine (NASEM) to undertake a transparent and impartial systematic review of the evidence in favour of puberty-blocking drugs 

- emanate requests for long-term studies on children given transpuberal drugs, as long-term data "are of fundamental importance and severely lacking"

- create a web page disclosing the known and potential risks of off-label puberty blocking to "help counter widespread confusion and the disinformation on this use'

"Many in the medical profession and in the media continue to portray the off-label use of puberty blockers as 'well-established' and 'life-saving''', states the petition.

"Although the FDA has taken an aggressive stance against medical misinformation in other contexts, never did anything to counter these false statements. "What is more worrying is that since puberty blockers are not FDA approved for children with gender dysphoria, there is no proven benefit of the drugs to justify these risks."

"This is why Sweden, Finland, the UK, Norway and other countries have all opposed the use of puberty blockers and other medical interventions as first-line treatment of gender dysphoria, recognising this use as experimental.

"The [American] public deserves its government to tell the truth on the potential harms of these drugs and the lack of established benefits

Puberty blockers are used off-label for gender dysphoria internationally, although brand names may vary from country to country.

"The FDA can address the misinformation surrounding the off-label use of puberty blockers in children by commissioning a systematic review of peer-reviewed studies existing by NASEM with the aim of developing an authoritative evaluation of the evidence,' the petition states.

The petition states that the gender affirmation treatment model used in the US lacks guarantees imposed by the Amsterdam gender clinic that pioneered the use of puberty blockers followed by cross-sex hormones and surgery in the late 1990s.

"Due to the prevalence of the affirmative model in the United States, the The number of children with gender dysphoria receiving puberty-blocking drugs has increased significantly, more than doubling between 2017 and 2021'..

"It is well known that these drugs interfere with bone development and fertility (if followed by cross-sex hormones) and there are serious concerns about their effect on long-term bone health and neurocognitive development

"What is most worrying is that this [poorly understood] security profile is currently tolerated in medicines prescribed for children for which the benefit is highly uncertain.'"

The petition emphasises the vulnerability of dysphoric children, who have 'higher rates of other psychological and developmental conditions, including autism, eating disorders and depression'.

The petition also calls on the FDA to warn pharmaceutical companies and health professionals of the consequences of illegally promoting puberty blockers for children with dysphoria.

"Puberty blockers were marketed directly to adolescents with promotions that designate them as a safe way to 'pause puberty', without disclosing any of the necessary risk information,' the petition states. "One example, thePlanned Parenthood ad broadcast for the first time in 2022 , a cartoon representing two teenagers speaking directly to potential users, stating: "The [p]uberty blockers are safe and can give you more time to understand what is right for you, your body and your gender identity'. e 'our gender identity is real'. You should decide what changes you want to make to your body".

The petition states: 'Pharmaceutical companies promoting their drugs for off-label uses have paid multimillion-dollar settlements to avoid civil and criminal judgments.  But the potential harm to users does not depend on who publishes the advertisement: promotions by professionals who overestimate the benefits of off-label use and fail to disclose the risks have the same potential as misleading consumers.

 (translation and adaptation by Marina Terragni)

Much of the news published by Feminist Post you will not read elsewhere. That is why it is important to support us, even with a small contribution: Feminist Post is produced solely by the voluntary work of many people and has no funding.
If you think our work can be useful for your life, we will be grateful for even the smallest contribution.

You can give us your contribution by clicking here: Patreon - Feminist Post
You might also be interested in
14 April 2024
Hormone-addicted children: an in vivo trial. Who will pay for it?
Hilary Cass, the British paediatrician who produced a monumental report on 'affirmative therapy' for minors does not mince words: those children 'were used as footballs'. There has never been any evidence that puberty blockers work, that they reduce suicide risk, that they increase patients' well-being: far from it. Will those who, in the absence of scientific certainty, have inflicted these treatments, who have even persecuted so many people of goodwill determined to expose the scandal in the name of truth, go unpunished? Keira Bell, the best known detransitioner, hopes for criminal consequences
Englishwoman Keira Bell, a former patient of the Tavistock Clinic in London, is certainly the most famous of the de-transitioners. After the publication of the Cass Review she tells The Times that she would like to see criminal proceedings started so that the children treated by the clinic with puberty blockers and hormones can finally get justice. Keira is now 27, judges the treatment she was subjected to -blockers, hormones, removal of breasts- "experimental at best, destructive at worst" and believes the professionals have [...]
Read now
10 April 2024
UK. Cass report: no more affirmative therapy for children with gender-related problems
Pediatrician Hilary Cass' final report on child transitions comes out: offering affirmative therapy was a failure. There is no evidence on the effectiveness of puberty blockers, which should never be prescribed except in rare cases. Hormones of the opposite sex should not be given before the age of 18, and even between 18 and 25 caution should be exercised. A definitive watershed
The long-awaited final report of the Cass Review, an independent review chaired by paediatrician Hilary Cass on public health services for children and young people with 'gender dysphoria', came out this morning. Its final report and recommendations were presented to NHS England. Here are the highlights. The condemnation for affirmative therapy is final, and determined by the absolute lack of evidence that puberty blockers and opposite-sex hormones bring real benefits to children suffering from 'gender incongruence [...]
Read now
28 March 2024
Hormone therapies on children: doctors' insurances start to run away
The risk of million-dollar claims by minors undergoing irreversible treatment who regret the 'affirmative therapy' is too high: this is why some insurance companies no longer feel like covering 'gender medicine' under their policies
Those who resist the market for the transition of gender non-conforming girls and boys know very well that almost always the turning point - as was the case in the UK with Keira Bell and in the US with Chloe Cole - is the lawsuit brought by a former child-or treated-or with blockers and hormones against the doctors who administered the 'therapy': the detransitioners' side is decisive. Then the game becomes money versus money: the money collected by the gender clinics versus the money they end up [...].
Read now
23 March 2024
Also in Wyoming stop the transition of minors
It is the 24th US state to ban drug and surgical treatments on the bodies of gender non-conforming girls and boys. Doctors and practitioners who continue to prescribe affirmative therapy will lose their licences. Decisive in the passage of the law was the testimony - and legal action - of detransitioner Chloe Cole. A regulation banning trans-indoctrination in schools was also approved.
From next 1 July, hormone treatments and gender transition surgery of minors will be banned in Wyoming. With the passage of the law, Senate File 99, Wyoming will join 23 other US states, from Alabama to West Virginia, that have banned or severely restricted gender-affirming medicine on minors. Under the law, doctors, pharmacists and other health care providers who provide gender-affirming care could have their licences suspended or revoked. Opposed by Governor Mark Gordon, [...]
Read now
12 March 2024
The UK has decided: no more puberty blockers for children with dysphoria. It is the ultimate turning point (in memory of Yarden Silveira, 1998-2021, killed by 'sex change')
Not only the stop at the Tavistock Clinic: no British centre for 'gender non-conforming' girls and boys will be able to prescribe puberty blockers any more. The approach will have to be solely psychological: a resounding turning point that will have knock-on effects all over the world, including Italy. One of the biggest scandals in the history of medicine is finally coming to an end: will someone pay for the thousands of irreversibly damaged minors? Recalling here one among them who lost his life because of the unscrupulousness of doctors and surgeons
The British National Health Service (NHS) announces that PUBERTY BLOCKERS WILL NO LONGER BE ADMINISTRATED TO MINORS WITH GENDER Dysphoria: this is huge and heart-warming news after years and years of fighting on the front line. So not only is the dedicated service of the Tavistock Clinic in London closing, but no centre for the treatment of minors with dysphoria will use puberty blockers any more. The decision, described as 'historic', will have knock-on effects worldwide, [...].
Read now
6 March 2024
WPATH scandal: 'therapies' for children with dysphoria are improvised and prescribed without real consent
The World Professional Transgender Health is considered the leading global scientific and medical authority on 'gender medicine': over the past decades its standards of care have shaped the guidelines, policies and practices of governments, medical associations, public health systems and private clinics worldwide, including the WHO. But leaked documents reveal the neglect of children -including children with severe mental disorders- subjected to improvised treatments, without taking into account the long-term consequences and without being sure they were clear about what they were doing
The news manages to shock even those who have long fought against affirmative therapy - puberty blockers, hormones and surgery - for gender non-conforming minors, such as psychoanalyst David Bell who exposed the scandal at the Tavistock Clinic in London: 'Even for me the contents of these files are shocking and disturbing,' he said. "The files suggest that some WPATH members are aware that gender-affirming treatments sometimes cause very serious harm and [...]
Read now
1 2 3 56